Trinity Biotech (TRIB) Profit After Tax Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) Profit After Tax Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Trinity Biotech | 111.52 Mn | 106.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,612.32% |
| Sep 30, 2024 | -8,519.92% |
| Jun 30, 2024 | -2,942.92% |
| Mar 31, 2024 | -4,959.98% |
| Dec 31, 2023 | 26.05% |
| Sep 30, 2023 | -77.81% |
| Jun 30, 2023 | -5,697.98% |
| Mar 31, 2023 | -5,015.43% |
| Dec 31, 2022 | 24.57% |
| Sep 30, 2022 | -78.07% |
| Jun 30, 2022 | -67.58% |
| Mar 31, 2022 | -4,616.47% |
| Dec 31, 2021 | -1,133.24% |
| Sep 30, 2021 | 35.76% |
| Jun 30, 2021 | -20.24% |
| Mar 31, 2021 | 27.18% |
| Dec 31, 2020 | -42.94% |
| Sep 30, 2020 | -9.79% |
| Jun 30, 2020 | -14.87% |
| Mar 31, 2020 | -14.87% |